课题基金 / 基金详情

Training Program in Substance Use, HIV and Related Infections

Training Program in Substance Use, HIV and Related Infections
药物滥用、艾滋病毒及相关感染培训计划
批准号:
9923606
负责人:
Thomas L. Patterson
金额:
$47.23万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-05 至 2022-06-30

项目摘要

项目成果

Thomas L. Patterson的其他基金

相似基金

相关文献

中文摘要
翻译
要求更新资金以继续T32培训方案,以培训下一代预防 在艾滋病毒和相关药物使用者的共病方面具有专业知识的科学家。我们的计划建立在 公共卫生、临床心理学的三个联合博士项目和一个跨学科研究的新博士 关于加州大学圣地亚哥分校(UCSD) 医学院和圣地亚哥州立大学公共卫生和社会工作研究生院。我们的 目标是:1)为博士前提供跨学科研究培训经验的机会 希望专注于流行病学、健康行为和心理学的学生和博士后研究员 药物使用与艾滋病毒或其他传染病(如病毒)交叉的预防研究 肝炎、结核病、性传播感染)或合并症;2)为学生提供艾滋病毒及相关研究的实践经验 注射吸毒、艾滋病毒及相关疾病负担最重的国际环境中的共病 感染;3)招募和培训来自不同学术背景和代表性不足的研究人员 少数群体(URM)拥有成为独立研究人员所需的工具,拥有最先进的 应对药物使用者艾滋病毒预防研究中的高度优先挑战的技能;以及4)培训 在与人类受试者进行负责任的研究中的个人,特别是在国际和交叉领域 文化背景。在过去的4年里,我们的项目支持了31名实习生(12名博士前和19名博士前 博士后研究员;12名(39%)为URM)。完成培训的学员(8名博士后和16名博士后),除1名外,其余均为 博士后和1名博士后仍在该领域工作。攻读预科博士的平均时间为4.1年。三 已完成的博士后是助理教授,两位是由其他NIDA T32资助的博士后,两位是在 包括研究在内的应用职位。新授予博士后7名K01,还有3名悬而未决 这些人中有一半是URM。我们的31名博士后和博士后分别发表了82篇和141篇稿件, 其中近一半是第一次创作的。我们请求支持4名博士后和4名博士后实习生, 他们将从25名P受体中接受指导。根据学员的培训水平,学员将完成 物质使用和传染病课程,负责任的研究指导,季刊 文化敏感度培训讲习班、关于科学严谨性的研讨会、关于“正在进行的工作”的演讲,以及 新的研讨会(例如,写作圈)。我们在邻近的墨西哥(6个R01)和其他几个正在进行的研究项目 国际环境提供了独特的、亲身实践的国际培训体验和强大的 为受训人员发展成为独立调查人员提供基础设施。
英文摘要
Renewed funding is requested to continue a T32 training program to train the next generation of prevention scientists with expertise in HIV and related co-morbidities among substance users. Our program builds upon three joint doctoral programs in public health, clinical psychology and a new PhD in Interdisciplinary Research on Substance Use offered in partnership between the University of California San Diego (UCSD) School of Medicine and the San Diego State University (SDSU) Graduate Schools of Public Health and Social Work. Our objectives are: 1) To provide opportunities for interdisciplinary research training experiences for pre-doctoral students and postdoctoral fellows in epidemiology, health behavior and psychology who wish to focus on prevention research at the intersection of substance use and HIV or other infectious diseases (e.g. viral hepatitis, TB, STIs) or comorbidities; 2) To offer students hands-on experience in the study of HIV and related comorbidities in international settings which bear the greatest burden of injection drug use, HIV and related infections; 3) To recruit and train researchers from diverse academic backgrounds and under-represented minority populations (URM) with the tools needed to become independent researchers with state-of-the-art skills to address high priority challenges in HIV prevention research among substance users; and 4) To train individuals in the responsible conduct of research with human subjects, especially in international and cross- cultural settings. During the past 4 years, our program supported 31 trainees (12 predoctoral and 19 postdoctoral fellows; 12 (39%) were URM). Of completed trainees (8 predocs and 16 postdocs), all but 1 predoc and 1 postdoc are still active in the field. Time to matriculation for predocs averaged 4.1 years. Three completed predocs are Assistant Professors, 2 are postdocs funded by other NIDA T32s, and two are in applied positions that include research. Seven K01s were newly awarded to postdocs with 3 more pending NGAs; half of these were URM. Our 31 predocs and postdocs published 82 and 141 manuscripts, respectively, almost half of which were first authored. We request support for 4 predoctoral and 4 postdoctoral trainees, who will be mentored from a pool of 25 Preceptors. Depending on their level of training, mentees complete courses in substance use and infectious diseases, instruction in responsible conduct of research, quarterly cultural sensitivity training workshops, seminars on scientific rigor, presentations on 'Work In Progress', and new seminars (e.g., Writing Circle). Our active research projects in nearby Mexico (6 R01s) and several other international settings offer the opportunity for unique, hands-on international training experiences and a robust infrastructure for trainees to develop into independent investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Texting intervention to sustain HIV prevention in women in high-drug-use contexts
Texting intervention to sustain HIV prevention in women in high-drug-use contexts
Texting intervention to sustain HIV prevention in women in high-drug-use contexts
HIV case finding and genetic transmission networks among MSM in Tijuana, Mexico
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究